Political situation
Written by: Wen Weiguang
2021-05-30 19:23
Last update date: 2021-05-30 19:23
The "Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Forum" hosted by the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance was held yesterday (29th). Huang Dadong, the chairman of the alliance and the convener of the event, proposed to combine the advantages of 9+2 parties to integrate resources and promote the Greater Bay District biotechnology development.
According to the vision of the "14th Five-Year Plan", Hong Kong will be further integrated into the Greater Bay Area, and the development of biotechnology in the Greater Bay Area will usher in new opportunities.
He said that the alliance will strive to promote the interconnection of talents, capital, technology, and data in the field of biotechnology.
+9
+9
+9
The chairman of the alliance, Yu Changhai, said that the 14th Five-Year Plan mentions the establishment of an international innovation and technology center in Hong Kong. He believes that the country has clear arrangements for Hong Kong and can use the advantages of Hong Kong as an international city to allow biotechnology to spread to the world.
He mentioned that Hong Kong has scientific research advantages. There are a total of 7 universities and a large number of biotech companies in science and technology parks for scientific research, which can cover the upstream, midstream and downstream biotech industry chain.
The National Committee of the Chinese People's Political Consultative Conference member and doctor Gao Yongwen said that the Greater Bay Area's demand for high-level medical services is increasing.
In addition, Hong Kong is currently discussing with the mainland authorities to use the Hong Kong University Shenzhen Hospital as a pilot to use Hong Kong registered drugs. It is hoped that the authorities can extend the plan to other Hong Kong-funded hospitals and fully implement the "Hong Kong Medicine and Hong Kong Medicine" policy as soon as possible.
Greater Bay Area | Gao Yongwen advocates the development of Hong Kong medicine and Hong Kong medicine in Changhai: Hong Kong can develop the biotechnology industry chain
Xu Zhengyu from the Bureau of Finance and Treasury: Strengthen interoperability with the Greater Bay Area in the future, and hope that Licaitong can be extended to insurance products
Greater Bay Area